Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Center for Genetics at Saint Francis Saint Francis Hospital United States | 1 | 1 |
|
Cardiology Sequencing- Arrhythmia Comprehensive Panel (134 Genes) Genesys Diagnostics Genesys Diagnostics, Inc. United States | 88 | 134 |
|
Cardiology Sequencing- Full Panel (174 Genes) Genesys Diagnostics Genesys Diagnostics, Inc. United States | 122 | 174 |
|
Carrier Screening - Comprehensive Panel (145 Genes) Genesys Diagnostics Genesys Diagnostics, Inc. United States | 185 | 145 |
|
FXN Gene Friedreich ataxia NGS Genetic DNA Test DNA Labs India India | 1 | 1 |
|
Mayo Clinic Laboratories Mayo Clinic United States | 1 | 211 |
|
Mayo Clinic Laboratories Mayo Clinic United States | 2 | 128 |
|
Peripheral Neuropathy Gene Panel Mayo Clinic Laboratories Mayo Clinic United States | 1 | 186 |
|
Mayo Clinic Laboratories Mayo Clinic United States | 1 | 199 |
|
FXN, Repeat Expansion Analysis Mayo Clinic Laboratories Mayo Clinic United States | 3 | 1 |
|
Frataxin (FXN) gene GAA triplet repeat test Neurogenetics Cyprus Institute of Neurology and Genetics Cyprus | 1 | 1 |
|
Friedreich Ataxia (FRDA) via the FXN GAA Repeat Expansion PreventionGenetics, part of Exact Sciences United States | 1 | 1 |
|
Genomic Unity® Nuclear Encoded Mitochondrial Gene Analysis Variantyx, Inc. United States | 1 | 335 |
|
Nuclear Mitochondrial Gene Panel Mayo Clinic Laboratories Mayo Clinic United States | 1 | 221 |
|
Combined mtDNA+Nuclear Gene Panel Mayo Clinic Laboratories Mayo Clinic United States | 12 | 221 |
|
Molecular Vision Laboratory United States | 1358 | 1028 |
|
FXN - Repeat expansion analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
FXN - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Centogene AG - the Rare Disease Company Germany | 406 | 414 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.